33231680|t|Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations.
33231680|a|OPA1 mutations are the major cause of dominant optic atrophy (DOA) and the syndromic form DOA plus, pathologies for which there is no established cure. We used a 'drug repurposing' approach to identify FDA-approved molecules able to rescue the mitochondrial dysfunctions induced by OPA1 mutations. We screened two different chemical libraries by using two yeast strains carrying the mgm1I322M and the chim3P646L mutations, identifying 26 drugs able to rescue their oxidative growth phenotype. Six of them, able to reduce the mitochondrial DNA instability in yeast, have been then tested in Opa1 deleted mouse embryonic fibroblasts expressing the human OPA1 isoform 1 bearing the R445H and D603H mutations. Some of these molecules were able to ameliorate the energetic functions and/or the mitochondrial network morphology, depending on the type of OPA1 mutation. The final validation has been performed in patients' fibroblasts, allowing to select the most effective molecules. Our current results are instrumental to rapidly translating the findings of this drug repurposing approach into clinical trial for DOA and other neurodegenerations caused by OPA1 mutations.
33231680	49	67	neurodegenerations	Disease	MESH:D019636
33231680	84	88	OPA1	Gene	4976
33231680	100	104	OPA1	Gene	4976
33231680	138	160	dominant optic atrophy	Disease	MESH:D029241
33231680	162	165	DOA	Disease	MESH:D029241
33231680	190	193	DOA	Disease	MESH:D029241
33231680	344	370	mitochondrial dysfunctions	Disease	MESH:D028361
33231680	382	386	OPA1	Gene	4976
33231680	456	461	yeast	Species	4932
33231680	487	492	I322M	ProteinMutation	tmVar:p|SUB|I|322|M;HGVS:p.I322M;VariantGroup:0;OriginalGene:74143;CorrespondingGene:4976;RS#:775371840;CorrespondingSpecies:10090
33231680	506	511	P646L	ProteinMutation	tmVar:p|SUB|P|646|L;HGVS:p.P646L;VariantGroup:2;CorrespondingGene:4976;CorrespondingSpecies:9606
33231680	658	663	yeast	Species	4932
33231680	690	694	Opa1	Gene	74143
33231680	703	708	mouse	Species	10090
33231680	746	751	human	Species	9606
33231680	752	756	OPA1	Gene	4976
33231680	779	784	R445H	ProteinMutation	tmVar:p|SUB|R|445|H;HGVS:p.R445H;VariantGroup:1;OriginalGene:74143;CorrespondingGene:4976;RS#:80356529;CorrespondingSpecies:10090;CA#:275012
33231680	789	794	D603H	ProteinMutation	tmVar:p|SUB|D|603|H;HGVS:p.D603H;VariantGroup:3;CorrespondingGene:4976;CorrespondingSpecies:9606
33231680	948	952	OPA1	Gene	4976
33231680	1006	1014	patients	Species	9606
33231680	1209	1212	DOA	Disease	MESH:D029241
33231680	1223	1241	neurodegenerations	Disease	MESH:D019636
33231680	1252	1256	OPA1	Gene	4976
33231680	Association	MESH:D019636	4976
33231680	Association	MESH:D028361	4976
33231680	Association	MESH:D029241	4976

